Tobias Piegeler

Prof. Dr. Tobias Piegeler

Department of Anesthesiology and Intensive Care, University Hospital Leipzig, Leipzig, Germany
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2024 in Cancers
Verified
Journal Article
Open access
PDF file
Lucillia BEZULucillia BEZU
Lucillia BEZU
DODilara Akcal Oksuz
Dilara Akcal Oksuz
MBMax Bell
Max Bell
DBDonal J. Buggy
Donal J. Buggy
ODOscar Díaz-Cambronero
Oscar Díaz-Cambronero
TGThe EuroPeriscope Group
The EuroPeriscope Group
Surgical excision of the primary tumor represents the most frequent and curative procedure for solid malignancies. Compelling evidence suggests that, despite its beneficial effects, surgery may impair immunosurveillance by triggering an immunosuppressive inflammatory stress response and favor recurrence by stimulating minimal residual disease. In addition, many factors interfere with the immune effectors before and after cancer procedures, such as malnutrition, anemia, or subsequent transfusion. Thus, the perioperative period plays a key role in determining oncological outcomes and represents a short phase to circumvent anesthetic and surgical deleterious factors by supporting the immune system through the use of synergistic pharmacological and non-pharmacological approaches. In line with this, accumulating studies indicate that anesthetic agents could drive both protumor or antitumor signaling pathways during or after cancer surgery. While preclinical investigations focusing on anesthetics’ impact on the behavior of cancer cells are quite convincing, limited clinical trials studying the consequences on survival and recurrences remain inconclusive. Herein, we highlight the main factors occurring during the perioperative period of cancer surgery and their potential impact on immunomodulation and cancer progression. We also discuss patient management prior to and during surgery, taking into consideration the latest advances in the literature.

11 February 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SMSarah Dorothea Müller
Sarah Dorothea Müller
JZJonathan S. H. Ziegler
Jonathan S. H. Ziegler
TPTobias Piegeler
Tobias Piegeler
The perioperative use of regional anesthesia and local anesthetics is part of almost every anesthesiologist’s daily clinical practice. Retrospective analyses and results from experimental studies pointed towards a potential beneficial effect of the local anesthetics regarding outcome—i.e., overall and/or recurrence-free survival—in patients undergoing cancer surgery. The perioperative period, where the anesthesiologist is responsible for the patients, might be crucial for the further course of the disease, as circulating tumor cells (shed from the primary tumor into the patient’s bloodstream) might form new micro-metastases independent of complete tumor removal. Due to their strong anti-inflammatory properties, local anesthetics might have a certain impact on these circulating tumor cells, either via direct or indirect measures, for example via blunting the inflammatory stress response as induced by the surgical stimulus. This narrative review highlights the foundation of these principles, features recent experimental and clinical data and provides an outlook regarding current and potential future research activities.

18 July 2018 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
CBChristian P. Both
Christian P. Both
JTJörg Thomas
Jörg Thomas
PBPhilipp K. Bühler
Philipp K. Bühler
ASAchim Schmitz
Achim Schmitz
MWMarkus Weiss
Markus Weiss
TPTobias Piegeler
Tobias Piegeler
Due to its potential beneficial effects, intra- and postoperative application of intravenous lidocaine has become increasingly accepted over the last couple of years, e.g. in patients undergoing laparoscopic surgical procedures. Based on its beneficial properties, lidocaine was introduced to the standard of care for all pediatric laparoscopic procedures in our institution in mid-2016. In contrast to adult care, scarce data is available regarding the use of perioperative intravenous lidocaine administration in children undergoing laparoscopic procedures, such as an appendectomy. Retrospective analysis of all pediatric patients undergoing laparoscopic appendectomy at the University Children’s Hospital Zurich in 2016. Perioperative data, as recorded in the electronic patient data management system, were evaluated for any signs of systemic lidocaine toxicity (neurological and cardiovascular), behavioral deterioration, as well as for hemodynamic instability. Additionally, the incidence of postoperative nausea and vomiting, administration of pain rescue medication, time to hospital discharge and to first bowel movement, as well as any postoperative complications were recorded. Starting on 01/07/2016, all patients undergoing laparoscopic surgery received intravenous lidocaine (1.5 mg/kg body weight (BW) bolus after induction of anesthesia followed by continuous infusion of 1.5 mg/kgBW/h). These patients were then compared to children without lidocaine administration who had undergone laparoscopic appendectomy between 01/01/2016 and 30/06/2016. Data of 116 patients was analyzed. Of these, 60 patients received lidocaine. No signs of systemic toxicity, neurologic impairment or circulatory disturbances were noted in any of these patients. A (non-significant) difference in the incidence of emergence delirium was observed (0 cases in the lidocaine group vs. 4 cases in the control group, p = 0.05). This retrospective analysis did not reveal any adverse effects in pediatric patients receiving intravenous lidocaine for laparoscopic appendectomy under general anesthesia. However, further trials investigating beneficial effects as well as pharmacokinetic properties of intravenous lidocaine in children are required.

1 January 2016 in International Anesthesiology Clinics
Verified
Journal Article
Open access
TPTobias Piegeler
Tobias Piegeler
MHMarkus W. Hollmann
Markus W. Hollmann
ABAlain Borgeat
Alain Borgeat
PLPhilipp Lirk
Philipp Lirk
Cancer is one of the leading causes of morbidity and mortality worldwide, with about 14 million estimated new cases and 8 million deaths annually.1 For solid tumors such as breast cancer, surgical removal remains an essential and vital part of the overall treatment strategy.2 However, the perioperative period is increasingly recognized as a timepoint with the potential to influence patient outcomes profoundly.3 First, the mechanical process of tumor resection and subsequent regenerative processes may promote the recurrence of local residual disease. Second, perioperative immunosuppression may impair the host’s ability to attack circulating tumor cells (CTCs) or distant micrometastases. Third, some drugs administered perioperatively, such as opioids, have been alleged to promote tumor growth in their own right.3 Therefore, theoretically, regional anesthetic strategies, using local anesthetics to reversibly block nerve impulse propagation, seem to be ideally suited to treat perioperative cancer patients. These techniques, among their other effects, decrease the surgical stress response, preserve the patient’s immune system to a greater extent than general anesthesia, and reduce the need for opioids.4,5 In addition to these indirect effects, direct cytotoxic effects of local anesthetics on tumor cells as well as modulation and inhibition of subcellular pathways essential to tumor progression and metastasis have been described experimentally.6 This review will thus aim to outline experimental and clinical evidence of how local anesthetics might be able to interfere with processes important for the pathogenesis of metastasis during the perioperative period and to summarize preclinical and clinical evidence supporting their use leading to a possible better patient outcome. CTCs are released from the primary tumor into the circulation or the lymphatic system and might then be able to form new metastases.7 The number of CTCs can be correlated with the patient outcome and has been established as an independent prognostic factor for survival in metastatic breast, colon, and prostate cancer.8 The concept of CTCs and their contribution to metastasis and therefore a possible worsened outcome was first described in 1963 and has gained more and more attention over the last couple of years.9 Depending on the type of tumor, the stage of the disease and possible prior treatments (eg, neoadjuvant chemotherapy), the number of CTCs that can be detected at a given timepoint during the course of the disease might differ substantially.10–12 However, it has also been demonstrated that there might be a significant increase in the release of CTCs during the perioperative period. For example, patients with pancreatic cancer13 might undergo a successful resection of a primary tumor, but still die from cancer recurrence due to new metastatic sites formed by the CTCs released during surgery.14 Therefore, the perioperative period might be crucial for the individual patient’s outcome and survival. During surgery, the patient’s body faces a phenomenon called the “stress response”: the release of several proinflammatory cytokines, such as interleukins and tumor necrosis factor α (TNFα), leads to a general proinflammatory state associated with the suppression of immune cell function.15,16 NK cells, a lymphocytic subset of the innate immune system,17 are involved in the first line of defense against infected and malignant cells.18,19 In rats, NK cell activity was significantly attenuated by stress and by surgical procedures (laparotomy), which subsequently also led to an increase in the retention of inoculated tumor cells in these animals.20 In humans undergoing surgery for breast, hepatocellular, or pulmonary carcinoma, a reduction of NK cell activity has also been observed.21 The influence of anesthetics on NK cell activity has been studied extensively.

Verified
Journal Article
Open access
PDF file
GHGunther Hempel
Gunther Hempel
AMAnne-Marie Maier
Anne-Marie Maier
TPTobias Piegeler
Tobias Piegeler
SSSebastian Stehr
Sebastian Stehr
JKJuergen Kratzsch
Juergen Kratzsch
CHClaudia Höhne
Claudia Höhne
Obesity in pediatric surgical patients is a challenge for the anesthesiologist. Despite potentially beneficial properties, propofol might also induce hypotension. This study examined whether a dose adjustment in overweight children could avoid hypotension and if there would be differences regarding hormonal regulation in children under anesthesia. Fifty-nine children undergoing surgery under general anesthesia were enrolled in this prospective observational trial. Participants were allocated into two groups according to their BMI. The induction of anesthesia was conducted using propofol (“overweight”: 2 mg/kgBW, “regular”: 3.2 mg/kgBW). The maintenance of anesthesia was conducted as total intravenous anesthesia. Hormone levels of renin, angiotensin II, aldosterone, copeptin, norepinephrine and epinephrine were assessed at different timepoints. Blood pressure dropped after the administration of propofol in both groups, with a nadir 2 min after administration—but without a significant difference in the strength of reduction between the two groups. As a reaction, an increase in the plasma levels of renin, angiotensin and aldosterone was observed, while levels of epinephrine, norepinephrine and copeptin dropped. By adjusting the propofol dosage in overweight children, the rate of preincision hypotension could be reduced to the level of normal-weight patients with a non-modified propofol dose. The hormonal counter regulation was comparable in both groups. The release of catecholamines and copeptin as an indicator of arginine vasopressin seemed to be inhibited by propofol.

14 September 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GHGunther Hempel
Gunther Hempel
WHWolfgang Heinke
Wolfgang Heinke
MSManuel Florian Struck
Manuel Florian Struck
TPTobias Piegeler
Tobias Piegeler
DRDaisy Rotzoll
Daisy Rotzoll
Endotracheal intubation is still the gold standard in airway management. For medical students and young professionals, it is often difficult to train personal skills. We tested a high-fidelity simulator with an additional quantitative feedback integration to elucidate if competence acquisition for airway management is increased by using this feedback method. In the prospective trial, all participants (n = 299; 4th-year medical students) were randomized into two groups—One had been trained on the simulator with additional quantitative feedback (n = 149) and one without (n = 150). Three simulator measurements were considered as quality criteria—The pressure on the upper front row of teeth, the correct pressure point of the laryngoscope spatula and the correct depth for the fixation of the tube. There were a total of three measurement time points—One after initial training (with additional capture of cognitive load), one during the exam, and a final during the follow-up, approximately 20 weeks after the initial training. Regarding the three quality criteria, there was only one significant difference, with an advantage for the control group with respect to the correct pressure point of the laryngoscope spatula at the time of the follow-up (p = 0.011). After the training session, the cognitive load was significantly higher in the intervention group (p = 0.008) and increased in both groups over time. The additional quantitative feedback of the airway management trainer brings no measurable advantage in training for endotracheal intubation. Due to the increased cognitive load during the training, simple airway management task training may be more efficient for the primary acquisition of essential procedural steps.